» Authors » Magdy Elkashab

Magdy Elkashab

Explore the profile of Magdy Elkashab including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 595
Followers 0
Related Specialty
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Marcellin P, Ahn S, Ma X, Caruntu F, Tak W, Elkashab M, et al.
Gastroenterology . 2015 Oct; 150(1):134-144.e10. PMID: 26453773
Background & Aims: Patients chronically infected with the hepatitis B virus rarely achieve loss of serum hepatitis B surface antigen (HBsAg) with the standard of care. We evaluated HBsAg loss...
2.
Borman M, Ladak F, Crotty P, Pollett A, Kirsch R, Pomier-Layrargues G, et al.
Hepatol Int . 2015 Jul; 7(2):592-9. PMID: 26201792
Purpose: Noninvasive tools for the detection of hepatic steatosis are needed. The Fatty Liver Index (FLI), which includes body mass index (BMI), waist circumference, triglycerides, and γ-glutamyl-transferase, has been proposed...
3.
Giannini E, Afdhal N, Sigal S, Muir A, Reddy K, Vijayaraghavan S, et al.
J Gastroenterol Hepatol . 2015 Mar; 30(8):1301-8. PMID: 25777337
Background And Aim: Thrombocytopenia is frequently observed in patients with chronic hepatitis C virus (HCV) infection and cirrhosis, although it can also be observed in patients without cirrhosis by a...
4.
Cooper C, Shafran S, Greenbloom S, Enns R, Farley J, Hilzenrat N, et al.
Can J Gastroenterol Hepatol . 2013 Nov; 28(1):35-40. PMID: 24212915
Background: Serum tumour necrosis factor-alpha (TNF-α) levels correlate negatively with hepatitis C virus (HCV) antiviral response. Objectives: To test the hypothesis that a single infliximab induction dose would positively influence...
5.
Myers R, Pollett A, Kirsch R, Pomier-Layrargues G, Beaton M, Levstik M, et al.
Liver Int . 2012 Mar; 32(6):902-10. PMID: 22435761
Background: Accurate tools for the noninvasive detection of hepatic steatosis are needed. The Controlled Attenuation Parameter (CAP) specifically targets liver steatosis using a process based on transient elastography. Methods: Patients...
6.
Myers R, Pomier-Layrargues G, Kirsch R, Pollett A, Beaton M, Levstik M, et al.
J Hepatol . 2011 Oct; 56(3):564-70. PMID: 22027584
Background & Aims: The FibroScan XL probe facilitates liver stiffness measurement (LSM) by transient elastography (TE) in obese patients, yet factors affecting its accuracy have not been described. Our objectives...
7.
Myers R, Cooper C, Sherman M, Lalonde R, Witt-Sullivan H, Elkashab M, et al.
Can J Gastroenterol . 2011 Sep; 25(9):503-10. PMID: 21912762
Background: In patients chronically infected with the hepatitis C virus (HCV), it is not established whether viral outcomes or health-related quality of life (HRQoL) differ between individuals treated at academic...
8.
Myers R, Pomier-Layrargues G, Kirsch R, Pollett A, Duarte-Rojo A, Wong D, et al.
Hepatology . 2011 Sep; 55(1):199-208. PMID: 21898479
Unlabelled: Failure of liver stiffness measurement (LSM) by transient elastography (TE, FibroScan) and unreliable results occur in ≈ 5% and 15% of patients, respectively, mainly due to obesity. In this...
9.
Myers R, Elkashab M, Ma M, Crotty P, Pomier-Layrargues G
Can J Gastroenterol . 2010 Dec; 24(11):661-70. PMID: 21157581
Background: Liver stiffness measurement (LSM) using transient elastography (TE) is a promising tool for the noninvasive assessment of hepatic fibrosis. Objectives: To determine the feasibility and performance of TE in...
10.
Myers R, Crotty P, Pomier-Layrargues G, Ma M, Urbanski S, Elkashab M
Liver Int . 2010 Sep; 30(10):1471-80. PMID: 20807336
Background And Aims: Liver stiffness measurement (LSM) by transient elastography (TE) is widely used for the noninvasive assessment of fibrosis. Our objectives were to examine the prevalence, risk factors and...